PEDIATRIC ONCOLOGY GROUP PARTICIPATION

中西部儿童癌症中心（MCCC）的目标是减少 通过早期诊断降低儿童癌症的发病率和死亡率， 评估、治疗、后续护理以及临床和实验室 research. 在实现这些目标方面取得的成就包括： 位于威斯康星州东南部的一个癌症儿童转诊中心 针对医疗、辅助医疗和非专业人员的癌症教育方案; 合作方案（ALL、AML、神经母细胞瘤）; I-II期药物试验 骨髓移植计划;积极的家庭护理计划; 心理和社会支持团体;旨在评估 癌症治疗的后遗症;积极的肿瘤实验室研究 免疫学和药理学。 管理协委会与常设观察团建立联系的目的是 是为了提高我们为全国范围的努力做出贡献的可能性， 降低儿童癌症的发病率和死亡率。 MCCC将 与其他POG成员在免疫学领域合作， 药理学，并将我们的患者分配到POG方案。 我们将 参与设计白血病、实体瘤和新的 剂. 方案成功原因的实验室研究， 失败将伴随临床研究。 在共同环境中的参与 与其他对儿童癌症感兴趣的人合作， 对抗这些疾病。

The objectives of the Midwest Children's Cancer Center (MCCC) are to reduce the incidence and mortality from childhood cancers through early diagnosis, evaluation, treatment, follow-up care and clinical and laboratory research. Accomplishments towards these goals include establishment of: a referral center for children with cancer in southeastern Wisconsin; a cancer education program for medical, paramedical and lay personnel; cooperative protocols (ALL, AML, neuroblastoma); Phase I-II drug trials a bone marrow transplantation program; an active home care program; psychological and social support groups; protocols designed to evaluate sequelae of cancer treatments; active laboratory research in tumor immunology and pharmacology. The purpose of the MCC's affiliation with POG is to enhance our probability of contributing to the nationwide effort to reduce the incidence and mortality of childhood cancer. MCCC will collaborate with other POG members in the areas of immunology, pharmacology, and assignment of our patients to POG protocols. We will participate in design of protocols for leukemias, solid tumors, and new agents. Laboratory investigations of reasons for protocol successes and failures will accompany clinical studies. Participation in a common milieu with others interested in childhood cancers should enhance efforts to combat these diseases.